Outcomes shown are for the entire cohort reported in each study. Studies that include 4 or more conditioning regimens are reported as “various.” Only studies with greater than 20 patients reported in the past 5 years are depicted. For Viollier et al,51 only the most recent cohort (after 1998) reported is shown. The Marsh study reported on outcomes in 50 patients total, 21 of whom received an MSD HSCT and 29 a UD HSCT after Flu/Cy/Alem conditioning. The reported median age and rates of acute and chronic GVHD are for the entire cohort (all 50 patients). All acute GVHD cases in the Marsh study were grade I-II. Adapted with permission from Scheinberg and Young.1